NIH should reconsider the Epigenomics Roadmap Initative
87 signers. Add your name now!
87 signers. Almost there! Add your voice!
Maxine K. signed just now
Adam B. signed just now
The undersigned urge the National Institutes of Health to reconsider the Epigenomics Roadmap Initiative. The initiative should be recast to consider a broader approach that supports fundamental valuable scientific discovery into cell-type programming at all levels and in a variety of biological systems.